X-linked hypophosphatemia and burosumab: Practical clinical points from the French experience-Reference-Cited by-同舟云学术

X-linked hypophosphatemia and burosumab: Practical clinical points from the French experience

Published:2021-10 Issue:5 Volume:88 Page:105208
ISSN:1297-319X
Container-title:Joint Bone Spine
language:en
Short-container-title:Joint Bone Spine

Author:

Bacchetta Justine,Rothenbuhler Anya,Gueorguieva Iva^ORCID,Kamenicky Peter,Salles Jean-Pierre^ORCID,Briot Karine,Linglart Agnès

Publisher

Elsevier BV

Subject

Rheumatology

Reference35 articles.

1. Hypophosphatemic rickets: etiology, clinical features, and treatment;Pavone;Eur J Orthop Surg Traumatol,2015

2. Therapeutic effects of anti-FGF23 antibodies in hypophosphatemic rickets/osteomalacia;Aono;J Bone Miner Res,2009

3. Nationwide survey of fibroblast growth factor 23 (FGF23)-related hypophosphatemic diseases in Japan: prevalence, biochemical data, and treatment;Endo;Endocr J,2015

4. Orphanet. [Available from: https://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=FR&data_id=11911&Disease_Disease_Search_diseaseType=ORPHA&Disease_Disease_Search_diseaseGroup=89936&Disease(s)/group%20of%20diseases=XLH&title=XLH&search=Disease_Search_Simple].

5. Osteocyte regulation of phosphate homeostasis and bone mineralization underlies the pathophysiology of the heritable disorders of rickets and osteomalacia;Feng;Bone,2013

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. X-linked hypophosphatemia: The value of feedback focus groups to assess patient and caregiver needs;European Journal of Medical Genetics;2024-02

2. Raquitismos;EMC - Pediatría;2023-09

3. Transition of patients with metabolic bone disease from paediatric to adult healthcare services: current situation and proposals for improvement;Orphanet Journal of Rare Diseases;2023-08-29

4. Expert consensus on evidence-based recommendations for the diagnosis, treatment, and follow-up of X-linked hypophosphatemic rickets (XLH);2023-05-08

5. Consenso de expertos colombianos sobre recomendaciones basadas en evidencia para el diagnóstico, tratamiento y seguimiento del raquitismo hipofosfatémico ligado al cromosoma X (RHLX);2023-04-11